Cargando…
Translational Dysregulation in Cancer: Molecular Insights and Potential Clinical Applications in Biomarker Development
Although transcript levels have been traditionally used as a surrogate measure of gene expression, it is increasingly recognized that the latter is extensively and dynamically modulated at the level of translation (messenger RNA to protein). Over the recent years, significant progress has been made...
Autores principales: | Vaklavas, Christos, Blume, Scott W., Grizzle, William E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526920/ https://www.ncbi.nlm.nih.gov/pubmed/28798901 http://dx.doi.org/10.3389/fonc.2017.00158 |
Ejemplares similares
-
Hallmarks and Determinants of Oncogenic Translation Revealed by Ribosome Profiling in Models of Breast Cancer()
por: Vaklavas, Christos, et al.
Publicado: (2020) -
Small molecule inhibitors of IRES-mediated translation
por: Vaklavas, Christos, et al.
Publicado: (2015) -
Translational control of the undifferentiated phenotype in ER-positive breast tumor cells: Cytoplasmic localization of ERα and impact of IRES inhibition
por: Vaklavas, Christos, et al.
Publicado: (2018) -
IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells
por: Vaklavas, Christos, et al.
Publicado: (2016) -
Molecular Mechanisms of MYCN Dysregulation in Cancers
por: Liu, Ruochen, et al.
Publicado: (2021)